KP
Kanchan Popli
About Kanchan Popli
Data last updated:
Kanchan Popli is a Director at Desons Therapeutics Private Limited (since 2014). The company operates in Pharma. Desons Therapeutics Private Limited reported revenue of ₹3.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Desons Therapeutics Private Limited U74140HR2014PTC052104 | Director | 10 Mar 2014 | 2014 | ₹3.25 Cr (FY 2024) | Active |
Board colleagues of Kanchan Popli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prem Raj | 06787029 | Desons Therapeutics Private Limited | Director |
| Shakuntala | 08536484 | Desons Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanchan Popli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanchan Popli
Kanchan Popli currently holds 1 directorship: Desons Therapeutics Private Limited (Director, since 10 Mar 2014, revenue ₹3.25 Cr (FY 2024)).
Kanchan Popli was first appointed on 10 Mar 2014 as Director at Desons Therapeutics Private Limited.
The current boards of Kanchan Popli's companies include Prem Raj (Desons Therapeutics Private Limited), Shakuntala (Desons Therapeutics Private Limited).